See what’s happening at MBC BioLabs.
Astellas Golden Ticket Program 2026
Astellas is pleased to invite applications for the Astellas Golden Ticket Program, an initiative designed to support entrepreneurs and early-stage biotech companies developing differentiated scientific approaches with the potential to address significant unmet medical needs and advance patient care.
Applications can be submitted through October 23, 2026 at 11:59 PM PDT.
Astellas is pleased to invite applications for the Astellas Golden Ticket Program, an initiative designed to support entrepreneurs and early-stage biotech companies developing differentiated scientific approaches with the potential to address significant unmet medical needs and advance patient care.
Applications can be submitted through October 23, 2026 at 11:59 PM PDT.
We are delighted to announce ASERTI Pharmaceutical as the winner of the 2026 Ono Golden Ticket
MBC BioLabs and Activate Announce Oleo and Atelas as Winners of the 2026 Activate Green Ticket
The New Infrastructure of Biotech Entrepreneurship
October 7 @ 5:30pm – 7:30pm
Location:
San Francisco
BioPioneers x VCVillage – #SFTechWeek
October 8 @ 5:30pm – 7:30pm
Location:
135 Mississippi St, San Francisco
AI Wearables | Flexible Biosensors – #SFTechWeek
October 10 @ 11am – 1:30pm
Location:
135 Mississippi St, San Francisco
Brain Optimization Summit
October 11 @ 9:30am – 5:30pm
Location:
135 Mississippi St, San Francisco
Enabling Awesome: Cultivating a Culture of Kindness that Enables Human Potential and Scientific Discovery
When I walked into my first MBC BioLabs site as the company's new communications director, the first thing I saw was two words painted on the wall: Enabling Awesome.
My first reaction was mild skepticism, it reads like something a brand consultant workshopped. But the more time I've spent here, the clearer it's become that those words are the product of 20 years of treating that phrase as a guiding star.
Spotlight on Portal
As a doctoral student at the Massachusetts Institute of Technology, Armon Sharei built what he still calls a gun. Cells streamed single file through a microscopic channel, and a jet of fluid fired cargo at each one, in theory punching the payload through the membrane. It was, he says, "a very American approach to the problem" of engineering cells to fight disease.
Catalyzing Medicine: How Ridge Bio is Building Better Bioconjugates
Ridge Biotechnologies designs enzymes and targeted therapeutics that enable the next generation of precision medicines.
We sat down with CEO and co-founder Weston Kightlinger to learn how the company’s platform works, the problem it solves, and what’s next.